Further, we were also surprised to find that EpCAM2/TROP2 was not a prognostic factor, as overexpression of this gene has been shown to be associated with liver metastases and survival in CRC patients (Ohmachi et al, 2006). Here, TACSTD2 is linked to colorectal carcinoma.